Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Matucci

Showing results (141-150 of 156) with videos related to

Pageof 16
Sort By:
Pathogens and Global Health|November 19, 2025
A digital repository of samples from arthropod vectorsDavide Colombo, Alejandro Nabor Lozada-Chàvez, Andrea Matucci, et al.
Allergy|March 20, 2020
Biologicals in atopic disease in pregnancy: An EAACI position paperBirgit Pfaller, Juan José Yepes-Nuñez, Ioana Agache, et al.
International Journal of Immunopathology and Pharmacology|December 9, 2016
Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficienciesClementina Canessa, Jessica Iacopelli, Antonio Pecoraro, et al.
Current Allergy and Asthma Reports|March 13, 2024
Multidisciplinary Decision-Making-ITAlian Consensus After Two Years of Real Practice on the Management of Severe Uncontrolled CRSwNP by Biologics (ITACA Study)Eugenio De Corso, Carlotta Pipolo, Marco Caminati, et al.
Journal of Clinical Medicine|July 31, 2020
The Hidden Burden of Severe Asthma: From Patient Perspective to New Opportunities for CliniciansNicola Scichilone, Peter John Barnes, Salvatore Battaglia, et al.
The Journal of Clinical Investigation|May 29, 2020
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependentAlessio Mazzoni, Lorenzo Salvati, Laura Maggi, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 23, 2020
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary StudyAlessandra Vultaggio, Emanuele Vivarelli, Gianni Virgili, et al.
Cells|July 26, 2024
Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC)Marco Caminati, Luisa Brussino, Matilde Carlucci, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 24, 2021
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunityCinzia Milito, Vassilios Lougaris, Giuliana Giardino, et al.
Clinical and Translational Allergy|May 21, 2026
The Neglected Older Adults in Hereditary Angioedema: Insights From the ITACA RegistryFrancesca Perego, Azzurra Cesoni Marcelli, Riccardo Senter, et al.
Pageof 16

Showing results (141-150 of 156) with videos related to

Sort By:
Pageof 16
Pathogens and Global Health|November 19, 2025
A digital repository of samples from arthropod vectorsDavide Colombo, Alejandro Nabor Lozada-Chàvez, Andrea Matucci, et al.
Allergy|March 20, 2020
Biologicals in atopic disease in pregnancy: An EAACI position paperBirgit Pfaller, Juan José Yepes-Nuñez, Ioana Agache, et al.
International Journal of Immunopathology and Pharmacology|December 9, 2016
Shift from intravenous or 16% subcutaneous replacement therapy to 20% subcutaneous immunoglobulin in patients with primary antibody deficienciesClementina Canessa, Jessica Iacopelli, Antonio Pecoraro, et al.
Current Allergy and Asthma Reports|March 13, 2024
Multidisciplinary Decision-Making-ITAlian Consensus After Two Years of Real Practice on the Management of Severe Uncontrolled CRSwNP by Biologics (ITACA Study)Eugenio De Corso, Carlotta Pipolo, Marco Caminati, et al.
Journal of Clinical Medicine|July 31, 2020
The Hidden Burden of Severe Asthma: From Patient Perspective to New Opportunities for CliniciansNicola Scichilone, Peter John Barnes, Salvatore Battaglia, et al.
The Journal of Clinical Investigation|May 29, 2020
Impaired immune cell cytotoxicity in severe COVID-19 is IL-6 dependentAlessio Mazzoni, Lorenzo Salvati, Laura Maggi, et al.
The Journal of Allergy and Clinical Immunology. in Practice|June 23, 2020
Prompt Predicting of Early Clinical Deterioration of Moderate-to-Severe COVID-19 Patients: Usefulness of a Combined Score Using IL-6 in a Preliminary StudyAlessandra Vultaggio, Emanuele Vivarelli, Gianni Virgili, et al.
Cells|July 26, 2024
Managing Patients with Hypereosinophilic Syndrome: A Statement from the Italian Society of Allergy, Asthma, and Clinical Immunology (SIAAIC)Marco Caminati, Luisa Brussino, Matilde Carlucci, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 24, 2021
Clinical outcome, incidence, and SARS-CoV-2 infection-fatality rates in Italian patients with inborn errors of immunityCinzia Milito, Vassilios Lougaris, Giuliana Giardino, et al.
Clinical and Translational Allergy|May 21, 2026
The Neglected Older Adults in Hereditary Angioedema: Insights From the ITACA RegistryFrancesca Perego, Azzurra Cesoni Marcelli, Riccardo Senter, et al.
Pageof 16